You searched for Antibody candidate - Page 61 of 69

In Depth 19 Jan 2024

Re-coding the brain: Is CRISPR capable of curing neurodegenerative diseases?

…CRISPR/dCas9-editing strategy to lower the levels of APOE-e4. The lead candidate from this platform was found to reduce APOE-e4 levels in human induced pluripotent stem cell-derived miniature brains from an…

January 19, 2024 - 9 minutesmins - By Willow Shah-Neville

News and Trends 29 Jul 2016

Philogen targets Angiogenesis for cancer and Autoimmune Therapies

…monoclonal antibodies can be effective at targeting the neo-vasculature of tumors. Its work has yielded 5 candidates currently in clinical development. Of these, 4 target a variety of cancers (melanoma,…

July 29, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 5 Aug 2016

Dutch FF Pharma has a Promising Immunotherapy to fight Crohn’s Disease

…focuses on the immune system, developing an antibody that targets CD40 – a major regulatory receptor. CD40 seems to play a big role in a variety of autoimmune diseases. Its…

August 5, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 29 Jun 2016

Vienna-based Biotech raises €10M to fight Metabolic diseases and Parkinson’s

…cardiometabolic and neurodegenerative diseases as more candidates break into clinical development. Based at the Campus Vienna Biocenter (Austria), AFFiRiS is developing immunotherapies to prevent chronic diseases. Some of its targets…

June 29, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 31 Jan 2017

New British Biotech-Academia Alliance takes on Cardiovascular Disease

…key to treating many diseases, ranging from Alzheimer’s to cancer. However, their conformational flexibility in solution is a huge challenge that leads most candidates to fail. Heptares’ StaR technology addresses…

January 31, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 6 Feb 2020

Valbiotis Teams up with Nestlé to Reduce Type 2 Diabetes Risk

…Valbiotis’ lead candidate is a food supplement and not a medical treatment, the partners don’t legally need to complete clinical trials to take it to market. Therefore, they may decide…

February 6, 2020 - 2 minutesmins - By Jonathan Smith

In Depth 22 Feb 2024

TIL therapies: the impact on cancer research

…with is Obsidian Therapeutics, which is on a mission to limit toxicities when treating patients with melanoma. Its lead candidate OBX-115 is a TIL cell therapy that is genetically modified…

February 22, 2024 - 10 minutesmins - By Roohi Mariam Peter

brainvectis askbio gene therapy neurology

News and Trends 28 Apr 2020

AskBio Takes Over French Gene Therapy Company to Treat Alzheimer’s and Huntington’s

…manufacturing capacity will help to accelerate BrainVectis’ lead candidate for Huntington’s into phase I testing. In return, AskBio gets to expand its list of target indications. “AskBio recognized the scientific…

April 28, 2020 - 3 minutesmins - By David Kirk

News and Trends 10 May 2016

This UK Company told us how they Optimise Drug Development and turn a Profit

…III candidate for head and neck cancer. There are 2 key data readouts coming this year. One is a Phase III candidate for endometrial (womb) cancer with the Canadian partner…

May 10, 2016 - 4 minutesmins - By Dani Bancroft

In Depth 5 Apr 2023

Antimicrobial peptides: a promising class to tackle antimicrobial resistance

…down rapidly when they encounter bodily fluids, such as blood. They can also be costly to produce. However, efforts to create product candidates from antimicrobial peptides are expected to accelerate…

April 5, 2023 - 8 minutesmins - By Willow Shah-Neville

News and Trends 30 May 2023

Pancreatic cancer microbiome discovery holds treatment hope

…secure diverse IR candidates, the project involves comprehensive genomic and functional analysis of disease-associated microbiomes and bacteriophages. Additionally, the project aims to elucidate the mode of action (MoA) of IR-related…

May 30, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 15 Feb 2016

Celebrating the 10th Birthday of this German Infectious Disease Biotech with the CEO

…because this competitor drug, which is associated with side effects, doesn’t use the same mechanism of action as our molecule. Letermovir (AIC246/MK-8228) is an oral, once-daily antiviral candidate for prevention…

February 15, 2016 - 4 minutesmins - By Philip Hemme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Re-coding the brain: Is CRISPR capable of curing neurodegenerative diseases?

Philogen targets Angiogenesis for cancer and Autoimmune Therapies

Dutch FF Pharma has a Promising Immunotherapy to fight Crohn’s Disease

Vienna-based Biotech raises €10M to fight Metabolic diseases and Parkinson’s

New British Biotech-Academia Alliance takes on Cardiovascular Disease

Valbiotis Teams up with Nestlé to Reduce Type 2 Diabetes Risk

TIL therapies: the impact on cancer research

AskBio Takes Over French Gene Therapy Company to Treat Alzheimer’s and Huntington’s

This UK Company told us how they Optimise Drug Development and turn a Profit

Antimicrobial peptides: a promising class to tackle antimicrobial resistance

Pancreatic cancer microbiome discovery holds treatment hope

Celebrating the 10th Birthday of this German Infectious Disease Biotech with the CEO

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!